Tel: +263 242 708020, +263 242 705946 rsc@medsch.uz.ac.zw

Funding Opportunities

Grants

RFAs: Profound Autism Pilot Grant and Pre-Doctoral Fellowship Program

The Autism Science Foundation (ASF) is accepting applications for its Profound Autism Pilot Grant and Pre-Doctoral Fellowship Program, supporting research focused on the unique needs of individuals with profound autism. Funding is available for one-year pilot studies and pre-doctoral training projects that explore biological mechanisms, treatments, co-morbidities, and methodological challenges.

Due date: 6 March 2026

For more information click; https://autismsciencefoundation.org/apply-for-a-profound-autism-pilot-grant/

 

Clinical Cancer Research

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports truly innovative and unique patient-centered clinical trials that have the potential to positively impact the lives of cancer patients. Our overall goal is to improve treatment options and quality of life for cancer patients by funding studies focused on detection, treatment, and survivorship. We fund phase I to phase III interventional clinical trials. We do not fund, however, basic research, phase IV trials, or observational or epidemiological studies.

Due date: Letter of Intent is due March 9th, 2026

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

 

New 2026 LCRF Research Grant on Prevention and Early Detection in Lung Cancer

This funding mechanism is focused on identifying, characterizing, and developing approaches and techniques that will allow early detection and/or prevention of lung cancer and gaining insight into pre-neoplastic processes in the lungs. The ultimate goal is to detect lung cancer at the earliest stages and subsequently increase survival and survivorship. While this list is not exclusive, general areas of interest include:

  • Improvements in risk stratification of patients and uptake for screening
  • Identification and characterization of new biomarkers for NSCLC and SCLC
  • Development of predictive, diagnostic, or prognostic biomarkers
  • Liquid biopsy assays and related techniques
  • Genomic and histological approaches to improve early detection in tissue samples
  • Novel imaging and computational modalities to identify and risk stratify pre-neoplastic lesions
  • Implementation science with systematic uptake of evidence-based research findings into routine practices to improve quality and effectiveness of health services for early detection
  • Studies of pre-neoplasia and progression to lung neoplasia to inform prevention strategies
  • Development of pathways to increase uptake and utilization of lung cancer screening
  • Epidemiology studies to identify risk factors and implementation of prevention measures
  • Development of any new technologies that will aid in identifying early-stage lung cancers

Due date: Letter of Intent due 10 March 2026.

For more information, click: https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2026/

 

New 2026 LCRF Research Grant on Overcoming Resistance in Lung Cancer

Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer (including lung adenocarcinoma, squamous cell carcinoma and small cell lung cancer) and across the care continuum including newly designed targeted therapies and immunotherapies. These studies will enhance the momentum of improving lung cancer outcomes and have the potential to increase survivorship. We encourage applications on a wide variety of topics related to understanding and/or overcoming resistance including but not limited to:

  • Mechanisms of resistance to targeted therapies for oncogene-driven lung cancers. Proposals are encouraged in the areas of histological transformation, oligometastatic disease, oligo-remnant disease, uncommon mutations and non-genomic mechanisms of resistance.
  • Biology and mechanisms of drug resistance to lung cancer therapies including chemotherapy, immunotherapy, radiotherapy, and antibody drug conjugates.
  • Novel treatment approaches and new therapies to overcome and/or prevent resistance to lung cancer therapies.
  • Novel diagnostic approaches (i.e. biomarkers) to monitor treatment response and relapse.
  • Overcoming resistance in difficult to treat sites of metastases such as leptomeningeal and brain metastases.

Due date: Letter of Intent due 10 March 2026.

For more information, click: https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2026/

 

New 2026 LCRF Leading Edge Research Grant Program

the goal of the LCRF Leading Edge Research Grant Program is to fund innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, disparities, and social determinants of health research. The 2026 LCRF Leading Edge Research Grant Program will provide $150,000 over a period of two years for projects including but not limited to the following topics:

  • Lung cancer biology
  • Identification of new biomarkers
  • Machine learning and digital pathology
  • Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
  • Genetic and gene-environment interactions
  • Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
  • Mechanism of Antibody Drug Conjugates
  • Novel approaches to immunotherapy such as bispecific antibodies, vaccines, cellular therapies etc.
  • Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene therapy)
  • Supportive measures for people with lung cancer and their families, such as palliative care and telemedicine
  • Identification of metabolic vulnerabilities in lung cancer

Due date: Letter of Intent due 10 March 2026.

For more information, click: https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2026/

 

Gilead

Gilead welcomes funding requests for innovative, high impact projects that relate to at least one of our core therapeutic areas: Our grantmaking in Africa focuses on the following therapeutic areas: HIV/AIDS; Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including: Disease awareness; Disease prevention; Professional education; Improving patient access to care; Improving quality of care; Increasing scientific capacity; Strengthening healthcare systems. Funding requests must be submitted a minimum of 8 weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks. Formal notifications of all funding decisions are sent in writing by email to the contact listed on the grant application.

Due date: Grant applications are accepted throughout the year.

For more information, click: https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding

 

New Biostime Institute for Nutrition and Care Grant Program

The Biostime Institute for Nutrition and Care Grant Program supports innovative preclinical and clinical research in maternal and child nutrition and health. The programme funds high-impact studies focused on infant allergy prevention, early-life development, gut health, and immune support, with grants of up to €100,000 per project. The programme prioritises research proposals that address key challenges in early-life nutrition and development, including:

  • Infant allergy prevention and nutrition strategies
  • Child growth and developmental support
  • Postbiotic and gut health solutions
  • Maternal nutrition and health
  • Infant brain development
  • Infant immunity and allergy management

Projects should demonstrate clear relevance to early-life health outcomes and long-term wellbeing.

Due date: Letter of Intent is due March 15th, 2026

For more information, click: https://www.biostime-institute.com/research-funding/two-step-process

Genomics in Context Awards: collaborative research at the intersection of genomics, humanities, social sciences and bioethics

These awards will support transdisciplinary teams to catalyse research discoveries at the intersection of genomics, humanities, social sciences and bioethics. Funded projects will be given the time and resources to create new research agendas and explore innovative ways of working. The importance of social, ethical and legal work for guiding ethical, inclusive genomics research and related practices is widely acknowledged. Less recognised is the underexplored potential for the intersection between genomics, humanities and social sciences, and wider societal partners (including industry, policymakers and communities) to yield new research and discoveries. To date such collaborations have tended to be limited and late. This call is aimed at supporting novel and transdisciplinary teams to explore this intersection at the earliest stages of research ideation, design and partnership building. Collaborations could take many different forms and centre on a variety of areas of focus.

Due date: 16 March 2026

For more information, click: https://wellcome.org/research-funding/schemes/genomics-in-context-awards  

Organization for Autism Research Request for Applications

The Organization for Autism Research (OAR) seeks to fund studies that expand the body of knowledge related to autism intervention and treatment, produce practical and clearly objective results, have the potential to positively affect public policy, and provide outcomes that offer to enhance quality of life for persons with autism and their families. While applicants are always free to submit on any relevant area of research or intervention, this year, OAR will prioritize funding for early career investigators and projects that promote diversity, equity, and inclusion. Generally, OAR places special emphasis on research addressing the following areas:

Belonging and Interpersonal Skills; Communication and Language; Community-Based Assessment and Intervention; Community-Engaged Research; Community Living and Supports; Gender, Reproductive, and Sexual Health; Improving Access to and Effectiveness of Existing Systems and Services; Intersectionality, Equity, and Diversity; Mid-life and Older Adults; Physical Health and Mental Health

Study duration may range from one to two years.  

Letter of intent Due date: 16 March 2026, 11:59 PM ET

For more information, click: https://researchautism.org/researchers/applied-research/

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 – Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, and/or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs. This NOFO provides support for up to two years (R21 phase) for technology development and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for validation, larger-scale feasibility, and effectiveness studies. Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds. All applicants must address both the R21 and R33 phases.

Due date: 16 March 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-25-242.html

 

New LEO Foundation Research Grant Program (Round 2)

The LEO Foundation invites applications for its Research Grant Program, aimed at advancing dermatology research globally. The program prioritizes investigator-initiated projects that explore disease mechanisms, clinical challenges, and the broader impact of skin conditions on patients’ quality of life.

Due date: 19 March 2026 (16:00 CEST)

For more information click: https://leo-foundation.org/en/grants-and-awards/research-grants/

Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 26 March 2026, 15:00 GMT

For more information click: https://wellcome.org/research-funding/schemes/wellcome-career-development-awards

 

Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 31 March 2026, 15:00 BST

For more information click: https://wellcome.org/research-funding/schemes/wellcome-discovery-awards

New Neuroscience Capacity Accelerator For Mental Health (NCAMH)

This program aims to enhance neuroscience research related to mental health in Low- and Middle-Income Countries (LMICs), with a focus on building research capacity and accelerating the potential for impactful research programs, driving progress in understanding and addressing anxiety, depression and psychosis.

Due date: 31 March 2026

For more information click: https://ibro.org/grant/neuroscience-capacity-accelerator-for-mental-health/

New IBRO Collaborative Research Grants

These grants aim to foster international collaborations including emerging research groups. With the Collaborative Research Grants, our primary objective is to facilitate collaboration, whether between two emerging research groups or a combination of one emerging and one established research group. These grants aim to support various aspects of collaboration, including travel, accommodation, subsistence, and research expenses between the partnering groups. The awards are specifically designed to support direct collaboration costs and do not cover any indirect or overhead expenses.

Due date: 31 March 2026

For more information click: https://ibro.org/grant/collaborative-research-grants/

New Request for Proposals: Evaluating AI-Enabled Decision Support Tools for Frontline Workers in Primary and Community Health Care Settings

This RFP is issued by Wellcome Trust, the Gates Foundation, and the Novo Nordisk Foundation through the Evidence for AI in Health (EVAH) initiative, delivered in partnership with the Abdul Latif Jameel Poverty Action Lab (J-PAL) and the African Population and Health Research Center (APHRC).  EVAH seeks proposals to evaluate AI-enabled clinical decision support tools used by frontline community and primary health care workers in low- and middle-income countries within Sub-Saharan Africa, South Asia, and Southeast Asia.  We seek evaluations of AI-enabled clinical decision support tools (CDSTs) that:

  • Address cross-cutting PHC functions, including but not limited to triage, diagnosis, or referral across multiple conditions or patient populations.
  • Demonstrate integration within broader in-country health systems and service delivery pathways rather than stand-alone use cases. 
  • Show potential for horizontal scalability or adaptation across geographies, disease areas, or cadres of health workers. 

Due date: 1 April 2026 at 10:00am Eastern Daylight Time (4:00pm Central Africa Time; 7:30pm Indian Standard Time)

For more information click: https://www.povertyactionlab.org/initiative/evidence-ai-health-evah-initiative

New Climate Impacts Awards: Unlocking urgent climate action by making the health effects of climate change visible

The aim of this scheme is to make the impacts of climate change on physical and mental health visible to drive urgent climate policy action at scale. We will fund transdisciplinary teams to deliver short-term, high impact projects that can drive policy impact by combining evidence generation (or synthesis) with influencing and engagement strategies. This year, we have made changes to the research that will be supported through the scheme. As well as funding projects that fill evidence gaps on climate change-related health outcomes, we will also support research which builds the understanding of the economic implications of these climate change-related health outcomes. Read more about the 2026 scheme.

Due date: 8 April 2026, 15:00 BST

For more information click: https://wellcome.org/research-funding/schemes/climate-impacts-awards-unlocking-urgent-climate-action-making-health-2

New UNITAID Call for Proposals to Accelerate Cervical Cancer Elimination in LMICs

The focus is on enabling countries to implement routine, integrated services, strengthen supply and delivery systems while adopting innovative approaches that promote scale-up, sustainability and cost efficiency. Proposals should demonstrate alignment with national priorities, promote equity and long-term sustainability, and generate actionable evidence to catalyze global cervical cancer elimination. The objective of this Call for Proposals is to:

  • Introduce and scale innovative tools and approaches—including next-generation HPV diagnostics, digital health solutions, and cost-optimized delivery models—that improve efficiency, equity, coverage and quality of care across the care continuum.
  • Accelerate demand and adoption of cervical cancer secondary prevention and treatment services by supporting national and large subnational programs that are ready to establish routine, integrated services aligned with the global elimination strategy.
  • Promote equity, engagement of communities and women with lived experiences, and strong governance to ensure that interventions reach underserved populations, foster local relevance and ownership, and align with national strategies for long-term sustainability.
  • Strengthen supply and delivery systems to ensure sustainable, transparent, and efficient supply, procurement and distribution of cervical cancer commodities, embedded within broader women’s health and essential medicines supply chains.

Due date: 09 April 2026 at 12:00 CET

For more information click: https://unitaid.org/call-for-proposal/accelerating-cervical-cancer-elimination-through-secondary-prevention-in-low-and-middle-income-countries/

New Spencer Foundation Small Research Grants on Education Program

The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications two times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.

Due date: April 15, 2026 (12:00 noon Central time/North America)

For more information click: https://www.spencer.org/grant_types/small-research-grant

New IBRO Rising Stars Awards

Substantial support for early career investigators setting up new laboratories. By providing start-up grants for neuroscience laboratories, the Rising Stars Awards support the research needs of early career neuroscientists who either come from diverse and/or underrepresented backgrounds (racial/ethnic minorities, sexual orientation, special needs, etc) or lack substantial initial funds or grant support from other agencies. Additionally, they significantly impact their professional trajectories, by providing critical recognition for their research endeavours, supporting targeted capacity building and enabling the integration of cutting-edge methodologies and tools into their work. As a result, this program also enhances awardees’ chances of securing additional funding.

Due date: Applications open 15 March 2026 – 15 April 2026

For more information click: https://ibro.org/grant/rising-stars-awards/

New ICGEB Grants for Strengthening Biosecurity in Healthcare and Research Laboratories

The ICGEB Biosecurity Grants are awarded to support the implementation of activities that strengthen biosecurity, biosafety, pathogen detection, and outbreak preparedness in healthcare and research laboratories. An important element of successful applications is the feasibility of the proposed project within the designated timeframe (maximum 24 months). The maximum annual contribution from ICGEB is Euro 15,000. Funds can only be used to cover expenditures that are directly related to strengthening laboratory biosecurity and bio-preparedness. This may include essential laboratory equipment and materials relevant to biosecurity and pathogen detection; consumable items required for diagnostics and surveillance; training activities, including hands-on technical training and biosecurity capacity development; and travel costs directly related to project implementation.

Due date: 30 April 2026, 23:59 CET

For more information click: https://www.icgeb.org/grants/icgeb-grants-for-strengthening-biosecurity-in-healthcare-and-research-laboratories/

New ICGEB Research Grants 2026 CRP – Collaborative Research Programme

The ICGEB CRP Grants programme was established in 1988 and aims to stimulate collaborative research in Member States and with the ICGEB Component laboratories, promote training of young scientists, and facilitate the creation of appropriate research facilities. The programme supports research projects in basic science, human healthcare, industrial and agricultural biotechnology and bioenergy. A call for applications is launched yearly. Grants are awarded to contribute to the implementation of outstanding scientific research projects. An important element of successful applications is the feasibility of the proposed project within the designated timeframe (maximum 36 months). The maximum annual contribution from ICGEB is Euro 25,000.

Due date: 30 April 2026, 23:59 CET

For more information click: https://www.icgeb.org/grants/icgeb-research-grants-2023crp-collaborative-research-programme/

New OUCH-Int’l and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and Lung Cancer Prevalence

This award’s objective is to fund innovative projects to support research that examines the impact of climate change and environmental pollution on lung cancer risk, diagnosis, treatment, and outcomes and identifies strategies to mitigate these effects. Topics of interest include, but are not limited to:

  • Impact of climate change on cancer incidence and prevalence
  • Role of screening for lung cancer in a warming climate, particularly in never-smokers or anyone who falls outside of the screening guidelines
  • Understanding the impact of extreme weather events on lung cancer prevalence and outcomes (e.g., extreme weather events, severe heat, access to care, etc.)
  • Investigations into the role of air pollution and lung cancer in never-smokers
  • Research focused on the effects and interactions of environmental carcinogens and ways to mitigate their impact
  • Research into the mechanisms by which PM2.5 and other environmental carcinogens cause lung cancer

Due date: 2 June 2026.

For more information, click: https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2026/

 

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from low- and middle-income country (LMIC) and U.S. institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). FIC will support research training programs that focus on 1) major endemic or life-threatening emerging infectious diseases, 2) neglected tropical diseases, 3) infections that frequently occur as co-infections in HIV infected individuals or 4) infections or microbiomes associated with non-communicable disease conditions of public health importance in LMICs. Advanced scientific training related to prevention, treatment or public health approaches to any technical area of basic, epidemiological, clinical, behavioral or social science health research may be supported. Research training programs should incorporate didactic, mentored research and professional development skills components to prepare individuals for sustainable careers that will have significant impact on the priority health research needs of LMICs.

Due date: 6 August 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html

New Merck Stimulating Innovative Research Grant Program 2026

Since 2018, we have been offering research grants to encourage innovation in key areas that will shape the future. Grants of up to 500,000 € per year for up to 3 years have been made available. In 2026, grants are available in the areas further specified below.

  • In-vitro models and assays to identify novel therapies for neuroinflammatory diseases – one grant of up to 250,000 EUR per year for up to 2 years.
  • Artificial intelligence in cell culture media and process development – one grant of up to 150,000 EUR per year for up to 3 years.
  • Innovative approaches to economical remediation of contaminated high volume materials – one grant of up to 150,000 EUR per year for up to 2 years.
  • Condensate-based high-sensitivity cell-free screening assays for the modulation of protein-protein interactions  – one grant of up to 100,000 EUR per year for up to 3 years.
  • Advancing molecule synthesis and discovery – up to 3 grants each comprising a 1-year full Synthia® Retrosynthesis Software license, training, and extensive interaction with our scientists.

Due date: 31 August 2026

For more information click: https://www.merckgroup.com/en/research/open-innovation/research-grants.html

Fellowships and Scholarships

 

Royal Society Wolfson Visiting Fellowships

The Royal Society Wolfson Fellowships enable UK Universities and not-for-profit Research Institutions to attract and recruit internationally leading researchers (and their teams) to their organisation. The objectives of the Royal Society Wolfson Visiting Fellowships are to:

  • enable UK universities and research institutions to attract outstanding emerging or established international research leaders in key strategic areas to the UK from overseas
  • enable the Visiting Fellow and the host UK organisation to develop ongoing collaborative research links, share ideas and practice

Due date: 4 March 2026.

For more information click: https://royalsociety.org/grants/royal-society-wolfson-visiting-fellowship/

Newton International Fellowship

The Newton International Fellowship (NIF) programme provides support for outstanding early career researchers to make a first step towards developing an independent research career through gaining experience across international borders. The fellowships enable researchers to access expertise, gain new perspectives and build long-lasting collaborative relationships. This fellowship is for non-UK scientists who are at an early stage of their research career and wish to conduct research in the UK.

Due date: 11 March 2026.

For more information click: https://royalsociety.org/grants/newton-international/

 

British Academy International Fellowships 2026

The International Fellowships programme provides support for outstanding early career researchers to make a first step towards developing an independent research career through gaining experience across international borders. Each award is expected to involve a specific and protected research focus with the award holder undertaking high quality, original research. The overarching aim of the International Fellowships programme is to attract and retain emerging talent in the UK and build a globally connected, mobile research and innovation workforce. The objectives are to:

  • Attract talented International early career researchers to establish and conduct their research in the UK;
  • Support early career researchers to pursue high-quality and innovative lines of research;
  • Provide opportunities to acquire and transfer new skills and knowledge through training and career development;
  • Foster long-term relationships through networking opportunities and the International Fellowships alumni programme.

Due date: 11 Mar 2026 – 17:00 GMT

For more information click: https://www.thebritishacademy.ac.uk/funding/schemes/international-fellowships/

AACR Cancer Disparities Research Fellowship

The AACR Cancer Disparities Research Fellowship represents an effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research may be in basic, translational, clinical, or population sciences research and must have direct applicability and relevance to cancer disparities. The fellowship provides a two-year grant of $130,000 to support the salary and benefits of the fellow while working on mentored cancer disparities research. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

Due date: March 12, 2026 1:00 PM

For more information, click: https://www.aacr.org/grants/aacr-cancer-disparities-research-fellowship-aacr-grants/

2026 HIV Research Trust scholarships

The HIV Research Trust provides funding in resource-limited settings for early- to mid-career researchers working in all fields of HIV prevention, infection and treatment. Scholarships should enable the candidate to travel to another research unit (host institution) to acquire new skills and techniques which will develop the candidate’s career and add capacity to the department in which they are based (home institution). Examples of skills and techniques include: clinical management; clinical trial experience and practice; data and trial management; statistical expertise; acquisition of laboratory techniques and analyses; cell and molecular biology. Scholarships of up to £15,000 GBP are available, for tuition fees, laboratory costs, materials (consumables and shipping), international travel and subsistence. Scholarships are awarded annually, following a peer-review process led by HIV Research Trust trustees.

Due date: 11:00 BST on 30 March 2026.

For more information click:

https://r1.technology-trust-news.org/c/AQjgxxQQpYusAhj_uflfIIac7RsoiragD_QJsokfQyM-P7l8f9Z9Qh2CUedcPLcaUbnQ5A-M5SNZ

New IBRO Exchange Fellowships

The fellowships enable early-career neuroscientists to broaden the scope of their neuroscience training by conducting goal-directed laboratory visits. The Exchange Fellowships for neuroscience international internships are designed to cover travel and local expenses throughout the exchange period. Priority will be given to applicants from less developed and under-funded countries, in combination with efforts to ensure both gender and regional diversity.

Due date: 15 April 2026.

For more information click: https://ibro.org/grant/exchange-fellowships/

New Fulbright Foreign Student Program (Zimbabwe)

The U.S. Embassy invites applications for the 2027 Fulbright Foreign Student Program. This distinguished scholarship opportunity supports Zimbabwean university lecturers, researchers, and members of think tanks in pursuing advanced degrees at leading universities in the United States.

Due date: 30 April 2026

For more information, click: https://zw.usembassy.gov/apply-for-the-fulbright-foreign-student-program/

New Neuroscience Training Grants

This program provides dedicated funding to support early career neuroscientists from under-resourced regions in covering the costs of attending neuroscience training courses. Specialized teaching and hands-on training experiences are crucial for the career development of neuroscience researchers. The IBRO Neuroscience Training Grants are designed to support these essential opportunities, covering costs directly associated with the attendance of a neuroscience training course or school, such as fees, travel and accommodation. By eliminating financial barriers, IBRO aims to ensure that early-career neuroscientists, particularly those from under-resourced regions, can access high quality training. This initiative is part of IBRO’s broader commitment to promoting diversity, equity, and inclusion in neuroscience research and education. This program provides funding for early-career neuroscientists to attend neuroscience training courses.

Due date: Applications open 1 April 2026 – 15 May 2026.

For more information click: https://ibro.org/grant/neuroscience-training-grants/

New Nestlé Foundation Research Grants

The Nestlé Foundation offers different award and grant categories, some of them using a modular approach, i.e. the Pilot Grant Program represents the starting grant module for a later Full Grant Research application. The eligibility criteria as well as the Research objectives and topics have to be fulfilled independently from the award category (for further details see section “Specific information for applications”):

  1. Training Grant
  2. Pilot Grant
  3. Full Grant (small / large)

At present the Foundation’s work is primarily concerned with human nutrition research issues dealing with:

  • maternal and child nutrition, including breastfeeding and complementary feeding,
  • macro- and micronutrient deficiencies and imbalances,
  • interactions between infection and nutrition, and
  • nutrition education and health promotion.

Due date for Letter of Intent: N/A

For more information click; https://www.nestlefoundation.org/research.html

 

New RFAs: Profound Autism Pilot Grant and Pre-Doctoral Fellowship Program

The Autism Science Foundation (ASF) is accepting applications for its Profound Autism Pilot Grant and Pre-Doctoral Fellowship Program, supporting research focused on the unique needs of individuals with profound autism. Funding is available for one-year pilot studies and pre-doctoral training projects that explore biological mechanisms, treatments, co-morbidities, and methodological challenges.

Due date: 6 March 2026

For more information click; https://autismsciencefoundation.org/apply-for-a-profound-autism-pilot-grant/

 

New Clinical Cancer Research

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports truly innovative and unique patient-centered clinical trials that have the potential to positively impact the lives of cancer patients. Our overall goal is to improve treatment options and quality of life for cancer patients by funding studies focused on detection, treatment, and survivorship. We fund phase I to phase III interventional clinical trials. We do not fund, however, basic research, phase IV trials, or observational or epidemiological studies.

Due dates: Letter of Intent is due March 9th, 2026

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

 

New Genomics in Context Awards: collaborative research at the intersection of genomics, humanities, social sciences and bioethics

These awards will support transdisciplinary teams to catalyse research discoveries at the intersection of genomics, humanities, social sciences and bioethics. Funded projects will be given the time and resources to create new research agendas and explore innovative ways of working. The importance of social, ethical and legal work for guiding ethical, inclusive genomics research and related practices is widely acknowledged. Less recognised is the underexplored potential for the intersection between genomics, humanities and social sciences, and wider societal partners (including industry, policymakers and communities) to yield new research and discoveries. To date such collaborations have tended to be limited and late. This call is aimed at supporting novel and transdisciplinary teams to explore this intersection at the earliest stages of research ideation, design and partnership building. Collaborations could take many different forms and centre on a variety of areas of focus.

Due date: 16 March 2026

For more information, click: https://wellcome.org/research-funding/schemes/genomics-in-context-awards

 

New Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from low- and middle-income country (LMIC) and U.S. institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). FIC will support research training programs that focus on 1) major endemic or life-threatening emerging infectious diseases, 2) neglected tropical diseases, 3) infections that frequently occur as co-infections in HIV infected individuals or 4) infections or microbiomes associated with non-communicable disease conditions of public health importance in LMICs. Advanced scientific training related to prevention, treatment or public health approaches to any technical area of basic, epidemiological, clinical, behavioral or social science health research may be supported. Research training programs should incorporate didactic, mentored research and professional development skills components to prepare individuals for sustainable careers that will have significant impact on the priority health research needs of LMICs.

Due date: 6 August 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html

 

Fellowships and Scholarships

 

New International AIDS Society Scholarship applications are open

If you are at least 18 years old on 26 July 2026 and working, volunteering or studying in the area of HIV, you are welcome to apply for a scholarship for AIDS 2026. The IAS will award both in-person and virtual scholarships for AIDS 2026. Please select your preferred attendance type in your application, as well as the types of financial support you require to participate.

Due date: 27 January 2026 , 23:59 CET

For more information click: https://www.iasociety.org/conferences/aids2026/take-part/scholarships

 

New ANSO-CAS-TWAS/UNESCO PhD Scholarship

According to an agreement between the Alliance of International Science Organizations (ANSO), the Chinese Academy of Sciences (CAS) and The World Academy of Sciences (TWAS/UNESCO) for the advancement of science in developing countries, up to 40 students/scholars from developing countries will be sponsored to study in China for doctoral degrees for up to 4 years.

Due date: 31 January 2026

For more information click; https://twas.org/opportunity/anso-cas-twasunesco-phd-scholarship

 

The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship)

The SAHRI Fellowship programme empowers a new generation of skilled researchers to address critical gaps in health research and innovation in sub-Saharan Africa. The sub-Saharan Africa Health Research and Innovation Fellowship (SAHRI Fellowship) programme is an exceptional three-year training trajectory designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa (sSA) to become leaders in biomedical innovation and clinical research, tackling the urgent challenges of infectious disease prevention, diagnosis, treatment, and control across the region. The fellowship is fully funded by a grant from the Global Health EDCTP3 and implemented by a consortium of academic and research institutions from Europe and Africa, led by the Institute of Tropical Medicine Antwerp in collaboration with BioNTech.

Deadline for the 2026-2029 cohort: 1 February 2026

For more information, click: https://www.itg.be/en/research/projects/the-sub-saharan-africa-health-research-and-innovation-fellowship-program-sahri-fellowship?trk=public_post_comment-text

 

New Newton International Fellowship

The Newton International Fellowship (NIF) programme provides support for outstanding early career researchers to make a first step towards developing an independent research career through gaining experience across international borders. The fellowships enable researchers to access expertise, gain new perspectives and build long-lasting collaborative relationships.  This scheme is jointly run by the British Academy and the Royal Society.  The overarching aim of the Newton International Fellowship programme is to attract and retain emerging talent in the UK and build a globally connected, mobile research and innovation workforce. The objectives are to:

  • Attract talented international early career researchers to establish and conduct their research in the UK
  • Support early career researchers to pursue high-quality and innovative lines of research
  • Provide opportunities to acquire new skills and knowledge through training and career development
  • Foster long-term relationships through networking opportunities and the Newton International Fellowships alumni programme.

Due date: Open date 15 January 2026 and close date 11 March 2026

For more information click: https://royalsociety.org/grants/newton-international/

Path to a Cure — Pioneer Award

The goal of this request for applications is to identify ambitious basic research projects aiming to utilize cutting-edge techniques and strategies that have the potential to discover new genetic-based therapies for cystic fibrosis. This award is intended for exceptional investigators who have made significant, impactful contributions to their field of research. Academic programs supported through the Path to a Cure: Pioneer Award will focus on two core strategies to address the underlying cause of cystic fibrosis:

  • Restoring CFTR protein
  • Targeting the Root Cause of Disease

Due date: 5 December 2025

For more information click; https://www.cff.org/researchers/path-cure-pioneer-award

Spencer Foundation Research Grants on Education: Small

The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications two times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.

Due date: December 15, 2025, 12:00 pm (noon), Central Time

For more information click: https://www.spencer.org/grant_types/small-research-grant

 

New Genomics in Context Awards: collaborative research at the intersection of genomics, humanities, social sciences and bioethics

These awards will support transdisciplinary teams to catalyse research discoveries at the intersection of genomics, humanities, social sciences and bioethics. Funded projects will be given the time and resources to create new research agendas and explore innovative ways of working. The importance of social, ethical and legal work for guiding ethical, inclusive genomics research and related practices is widely acknowledged. Less recognised is the underexplored potential for the intersection between genomics, humanities and social sciences, and wider societal partners (including industry, policymakers and communities) to yield new research and discoveries. To date such collaborations have tended to be limited and late. This call is aimed at supporting novel and transdisciplinary teams to explore this intersection at the earliest stages of research ideation, design and partnership building. Collaborations could take many different forms and centre on a variety of areas of focus.

Applications open 11 November 2025

Due date: 16 March 2026

For more information, click: https://wellcome.org/research-funding/schemes/genomics-in-context-awards

New DKMS John Hansen Research Grant 2026

This is a Grant for the study of hematopoietic stem cell transplantation and cell therapy for hematological diseases. In honor of John A. Hansen, this grant is intended to provide financial support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematological diseases. The grant is funded by the foundation DKMS Stiftung Leben Spenden and administered by the DKMS Group gGmbH. The research proposal needs to address issues on hematopoietic stem cell transplantation or cell therapy for hematological diseases. Various aspects can be covered, including but not limited to: diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection, or cell manufacturing.

Due date: November 20, 2025, 23:59h (Central European Time).

For more information click: https://professional.dkms.org/research-publications/research-grant

New Early-Career Scientific Research Grants Program

The AABB Foundation awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine and biotherapies. Grant applications are evaluated on the basis of their scientific merit, relevance to and impact on transfusion medicine, focus and appropriateness to the scope of funding, and likelihood of yielding meaningful data.

Due date: 1 December 2025

For more information click: https://www.aabb.org/foundation/early-career-scientific-research-grants-program

New RARE Grant Program – Research Accelerating RUNX1 Exploration

The purpose of the grant is to fund research that will accelerate the discovery of druggable oncogenic pathways and deliver cancer interception and cancer prevention therapeutics for RUNX1-FPD children and family members. The RARE Grant is a two-year award designed to fund research that will lead to the development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevent blood cancer (before clonal hematopoiesis).  The RUNX1 Research Program hosts an annual scientific conference and patient meeting that brings together grant recipients and other scientists. Grant recipients are expected to present their progress as part of the annual review.

Due date: 11 December 2025, 8pm ET

For more information click: https://www.alexslemonade.org/researchers-reviewers/applicants

New Apply for Funding from the CMT Research Foundation

The mission of the CMT Research Foundation is to deliver treatments and cures for CMT during our lifetime. The CMT Research Foundation pursues this goal by identifying and bridging the gaps in biomedical research, with a focus on areas that are most likely to result in clinical treatments. Funding is provided to the most promising research for CMT that leads to the development of therapeutics for all types of CMT. The research priorities drive funding decisions, however, if an interesting approach or idea, they would want to hear from you.

Before submitting a full proposal, applicants must first submit a Letter of Intent.

Full proposals are accepted on a quarterly basis, with submission deadlines as follows:

Q1: December 17, 2025

Q2: February 18, 2026

Q3: May 20, 2026

Q4: August 12, 2026

LOIs submitted less than 6 weeks prior to these deadlines may be shifted to the next cycle for consideration at the Research Team’s discretion.

For more information click: https://cmtrf.org/apply/

 

New Melvin Yahr Parkinson’s Disease Clinical Research Award

The Melvin Yahr Parkinson’s Disease Clinical Research Award is jointly supported by the Parkinson’s Foundation and the International Association of Parkinsonism and Related Disorders (IAPRD). This award is designed to foster clinical research into any aspect of Parkinson’s disease conducted by young investigators who are under-represented in current research. By recognizing and honoring the exceptional contributions of young talented individuals, the award seeks to break down barriers and create a more inclusive and diverse healthcare community. It is expected that this initiative will spur innovation and promote the translation of cutting-edge scientific discoveries into efficient and practical health measures that will benefit people with Parkinson’s disease. The goal of the award is to prepare young neurologists specializing in Parkinson’s disease for a career in clinical research. Clinician scientists are uniquely positioned to be experts in both Parkinson’s disease research and care.

Due date: 12 January 2026

For more information click: https://www.parkinson.org/advancing-research/for-researchers/fellowships-early-career-awards#Melvin

 

New Emerging Researcher Award (ERA) Pilot Grants

The CMT Research Foundation values bringing fresh talent and thinking into the CMT research arena. To enable this, the ERA Pilot Grants are intended to support early-career researchers in the conduct of research projects aimed at testing innovative ideas to expand and advance drug development for Charcot-Marie-Tooth (CMT) disease. Awards will be prioritized to applicants that propose research projects with strong scientific merit and high potential to result in further research related to CMT drug development. For successful projects, follow-on funding from CMTRF may be a possibility. These grants specifically encourage the exploration of new ideas or concepts that are not currently or previously funded or explored.

OPTIONAL: Letter Of Intent submissions: 15 November 2025

Due date: January 30, 2026

For more information click: https://cmtrf.org/research/emerging-researcher-award/

New Emerging Researcher Award (ERA) Predoctoral Grants

ERA Predoctoral Grants are intended to support promising predoctoral fellows in the conduct of research projects aimed at testing new and innovative ideas that will expand or advance drug development for Charcot-Marie-Tooth (CMT) disease. Awards will be prioritized to applicants that propose research projects with strong scientific merit and high potential to result in further research related to CMT drug development. For successful projects, follow-on funding from CMTRF may be a possibility.

OPTIONAL: Letter Of Intent submissions: 15 November 2025

Due date: January 30, 2026

For more information click: https://cmtrf.org/research/emerging-researcher-award/

New IMS Career Development Award

The International Myeloma Society is proud to announce the sixth annual “IMS Career Development Award”. The IMS anticipates funding grants for young investigators focused on research in the field of plasma cell dyscrasias. Goal: To promote the development of the next generation of leaders in the field of plasma cell disorders. This award will also encourage interaction between institutions to enhance collaborative research.

Due date: January 30, 2026 at 11:59 pm EST.

For more information, click: https://www.myelomasociety.org/grants/ims-career-development-award/

New Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Due date: 17 February 2026, 15:00 GMT

For more information, click: https://wellcome.org/research-funding/schemes/wellcome-early-career-awards

Fellowships and Scholarships

 

New The Ibrahim Leadership Fellowships

The Ibrahim Leadership Fellowships were established in 2011 to identify and mentor the future generation of outstanding African leaders. Each year three Fellows have an opportunity to work in the executive offices of the AfDB (Abidjan), ECA (Addis Ababa) or the ITC (Geneva), with a stipend of $100,000.  During their 12-month programmes, Fellows gain both technical and leadership skills, while contributing directly to research and policy design. A special feature of the programme is the opportunity to benefit from the direct mentorship of the heads of the host organisations. Fellows also become members of the Now Generation Network (NGN), through which they continue to contribute their skills and insights to building a better Africa.

Due date: 20 November 2025

For more information click: https://mo.ibrahim.foundation/fellowships

New Harvard Learn, Engage, Advance, Disrupt “LEAD” Fellowship for Promoting Women in Global Health

To equip and empower more leaders in global health, the Harvard Global Health Institute, in collaboration with the Department of Global Health and Population at Harvard T.H. Chan School of Public Health, offers a transformational 1-year fellowship specifically designed to promote leadership skills in individuals from low- and middle-income countries who will, in turn, mentor future female leaders in global health.

Deadline for the 2026-2027 cohort: November 30th, 2025, 11:59PM EST.

For more information, click: https://globalhealth.harvard.edu/fellowships/harvard-lead-fellowship/#LEAD-Fellowship

New McDonald Fellowship

MSIF’s McDonald Fellowships fund 2-year research placements for early career researchers from low- and middle-income countries. The McDonald Fellowship enables early career multiple sclerosis researchers from low- and middle-income countries to work in a research institution outside of their own country. During the visit, participants either gain expertise or carry out parts of joint research projects. Following the award, we expect applicants will be able to use the newly developed expertise and networks, continuing to undertake MS research and/or patient care in low- and middle-income countries. The fellowship payment is a two-year grant, consisting of 55,000 EUR per year, paid to the host institution and then used to pay the fellow. One return flight to the host country will also be covered by the Fellowship.

Due date: 1 December 2025

For more information click: https://www.msif.org/research/awards-grants-and-fellowships/mcdonald-fellowships/

New The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship)

The SAHRI Fellowship programme empowers a new generation of skilled researchers to address critical gaps in health research and innovation in sub-Saharan Africa. The sub-Saharan Africa Health Research and Innovation Fellowship (SAHRI Fellowship) programme is an exceptional three-year training trajectory designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa (sSA) to become leaders in biomedical innovation and clinical research, tackling the urgent challenges of infectious disease prevention, diagnosis, treatment, and control across the region. The fellowship is fully funded by a grant from the Global Health EDCTP3 and implemented by a consortium of academic and research institutions from Europe and Africa, led by the Institute of Tropical Medicine Antwerp in collaboration with BioNTech.

Deadline for the 2026-2029 cohort: 1 February 2026

For more information, click: https://www.itg.be/en/research/projects/the-sub-saharan-africa-health-research-and-innovation-fellowship-program-sahri-fellowship?trk=public_post_comment-text

Trainings

 

New Human Gut Microbiome Metagenomics – Africa

This intensive training course is a collaboration between Wellcome Connecting Science, the Wellcome Sanger Institute, and the KEMRI-Wellcome Trust, and will provide early career researchers and scientists with cutting-edge skills in microbiome study design, sequencing, bioinformatics data analysis, and data interpretation. The course uses a blended learning model over three months, including pre-course modules, a 6-day residential workshop at KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya (12–17 April 2026), and post-course mentoring and networking activities. The residential workshop will combine lectures, hands-on sessions, seminars, and discussions, progressing from fundamentals of microbiome metagenomics to applied data analysis and interpretation and professional development.

Due date: 03 November 2025

For more information, click: https://coursesandconferences.wellcomeconnectingscience.org/event/human-gut-microbiome-metagenomics-africa-20260412/?dm_i=6Y2C,2QNE3,1GUODO,7M5MJ,1

New Antimicrobial Resistance of Bacterial Pathogens – Africa

n collaboration with the National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Services, Johannesburg, South Africa, we are pleased to announce our 2026 global training course in AMR of bacterial pathogens in Africa. This course aims to address regionally specific AMR-associated challenges through knowledge transfer and skills development by global experts. This week-long course will include an introduction to AMR with hands-on laboratory practicals for AMR detection through molecular and phenotypic testing accompanied by theoretical training on the evolution and spread of AMR and utilisation of whole-genome sequencing and bioinformatics analysis methods for AMR surveillance and control. It will also provide an opportunity for participants to network and potentially build a regional AMR community to support long-term partnerships and collaborations.

Due date: 03 November 2025

For more information, click: https://coursesandconferences.wellcomeconnectingscience.org/event/antimicrobial-resistance-of-bacterial-pathogens-africa-20260307/?utm_source=dotdigital&utm_medium=email&utm_campaign=amrafrica2026-email&utm_id=amrafrica2026&dm_i=6Y2C,2QNE3,1GUODO,7M5MJ,1


Colorectal Cancer Alliance PROJECT CURE CRC

The Colorectal Cancer Alliance (the Alliance) is pleased to announce a Request for Proposals (RFP) for preclinical, translational and clinical research with the potential for high impact on treatment and survivorship of colorectal cancer. Project Cure CRC will prioritize proposals that embrace moving colorectal cancer research to a curative science ASAP. Submitted proposals should focus on projects that are High-Risk/High-Reward and accelerate new therapies and technologies from bench to bedside. Projects that utilize collaborations and/or public-private partnerships are STRONGLY encouraged. Proposals will be accepted for Early-Career Investigator Awards, Senior Investigator Awards, Pilot Awards, Team Science Awards, and Opportunistic Awards from academic and industry researchers. The Alliance plans to award tens of millions in 2025 for new research and infrastructure needs arising from this RFP.

Types of Awards;

  • Young Investigator Accelerator Award (Academic and Non-profit Applicants Only)
  • Senior Investigator Accelerator Award (Academic and Non-profit Applicants Only)
  • Pilot Accelerator Award (Academic, Non-profit or Industry Applicants)
  • Team Science Accelerator Award (Academic, Non-profit and/or Industry)

Due date: There are no application deadlines. Applications will be accepted on a rolling basis starting on January 25th. A response regarding your proposal submission will be provided within two months of submission.

For more information, click; https://colorectalcancer.org/sites/default/files/media/documents/PRTMPL143852.PDF

 

Mental Health Award: Transforming early intervention for anxiety, depression and psychosis in young people

Funding for projects that robustly test the real-world effectiveness and assess implementation strategies of scalable transformative early interventions for anxiety, depression and psychosis in young people. This award is structured in two phases: a Foundation Phase followed by an Impact Phase;

Foundation Phase – This first phase of the funding call will provide teams with £200,000 to build their teams and develop their detailed proposal for their research study over 12 months. This research proposal must be for a definitive effectiveness study and assessment of strategies for implementation and scaling of a psychological and/or a social intervention. The proposal must capture multiple outcomes that are relevant to people with lived experience and implementing partners, including mental health outcomes, functional outcomes and full economic evaluation.

Impact Phase (open to applications February 2027).

In the second phase of the funding call, all teams from the Foundation Phase will be invited to apply for the Impact Phase.  We expect the award amount for the Impact Phase to be between £5 million and £8 million and the duration to be up to 5 years. The upper limits will be confirmed during the Foundation Phase.

Due date foundation stage: 11 November 2025

For more information click; https://wellcome.org/research-funding/schemes/mental-health-award-transforming-early-intervention#application-process-timeline-c42e

 

 

New ICPO Research Call for “AI-driven advancements in Precision Oncology“

The International Centers for Precision Oncology (ICPO) Foundation is committed to advancing the field of precision oncology through the strategic integration of Artificial Intelligence (AI). Recognizing unique challenges in a wider clinical adoption of Theranostics, ICPO has structured a series of research calls designed to systematically address and leverage AI-based enhancements of oncology care. More specifically, this initiative underscores the potential of foundational data curation, innovative prediction model development, and clinical validation to realize the transformative potential of AI in clinical oncology. This is a 3 year call series starting in 2025. To support the development of methodologies for curating and standardizing theranostics datasets—both imaging and non-imaging—by producing a structured database framework and annotation approach. This call focuses on the creation of data models, curation standards, and maintenance methods, without the collection or sharing of data at this stage. Any indication relevant to theranostics can be included.

Due date: 1 November 2025

For more information, click; https://www.icpo.foundation/icpo-research/ai-call-for-applications/

 

New Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 20 November 2025

For more information click; https://wellcome.org/research-funding/schemes/wellcome-career-development-awards

New Path to a Cure — Collaborative Research Grant

This program is intended to facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat cystic fibrosis with an emphasis on advancing CFTR gene repair and replacement approaches. Small molecule CFTR modulators that directly target the mutant protein are powerful therapies that will likely benefit 90% of people with CF in the near future. However, there is still a significant unmet need for people with CFTR mutations who do not respond to modulators, do not generate sufficient quantities of protein for correction, or block protein synthesis (i.e., premature stop codon mutations, splice site mutations, indels, etc.). To ensure all people with CF have access to effective CFTR-directed therapies, the Cystic Fibrosis Foundation announced the Path to a Cure initiative in 2019.  Projects supported through the Path to a Cure: Collaborative Research Grant should be ambitious in scope and utilize cutting-edge technologies and strategies that have the potential to inform or translate into novel therapies to restore CFTR protein function by fixing and/or replacing the defective CFTR gene.

Due date: 20 November 2025

For more information click; https://www.cff.org/researchers/path-cure-collaborative-research-grant

New Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 25 November 2025, 15:00 GMT

For more information click; https://wellcome.org/research-funding/schemes/wellcome-discovery-awards

Clinical Cancer Research

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports truly innovative and unique patient-centered clinical trials that have the potential to positively impact the lives of cancer patients. Our overall goal is to improve treatment options and quality of life for cancer patients by funding studies focused on detection, treatment, and survivorship. We fund phase I to phase III interventional clinical trials. We do not fund, however, basic research, phase IV trials, or observational or epidemiological studies.

Due dates: Letter of Intent is due November 23rd, 2025

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

New Gut Microbiota International Call for Projects

The Biocodex Microbiota Foundation founds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years.The grant is open to physicians, PhD’s and Pharm-D’s working in the subject area (gastroenterology, pediatrics, microbiology, infectious diseases and internal medicine, etc).There are no geographic limitations of applicants. Candidates from all countries are potentially eligible. A principal investigator having already received a Biocodex Microbiota Foundation international grant cannot apply anymore. However, principal investigator of a National Grant can apply for the International Grant.

The annual grant is set at €200,000 VAT included, independently of the duration of the project (between 1 and 3 years).

Due date: 30 November 2025 (24:CET)

For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects

New Path to a Cure — Pioneer Award

The goal of this request for applications is to identify ambitious basic research projects aiming to utilize cutting-edge techniques and strategies that have the potential to discover new genetic-based therapies for cystic fibrosis. This award is intended for exceptional investigators who have made significant, impactful contributions to their field of research. Academic programs supported through the Path to a Cure: Pioneer Award will focus on two core strategies to address the underlying cause of cystic fibrosis:

  • Restoring CFTR protein
  • Targeting the Root Cause of Disease

Due date: 5 December 2025

For more information click; https://www.cff.org/researchers/path-cure-pioneer-award

 

 

 

 

 

 

For Expired funding opportunities:

  Click here

CONTACT US

University of Zimbabwe
Faculty of Medicine and Health Sciences
Research Management Unit
Parirenyatwa Hospital Grounds

Tel: +263 242 708020, +263 242 705946

Email address

rscsacoreoffice@gmail.com

rsc@medsch.uz.ac.zw

Website

www.uzchsrsc.ac.zw

 Twitter

ttps://twitter.com/UZCHSRSC

Linkedin

https://www.linkedin.com/in/uz-fmhs-research-support-centre-995768267/

Research Management       Unit